Insulin oscillation blood from the pancreas to the liver, which is a major insulin target. Disturbances of the insulin oscillations occur early in type 2 diabetes and may contribute to insulin resistance. Pulsatile insulin delivery to the portal vein or islet cell transplantation to the liver of diabetic patients are therefore attractive therapeutic alternatives. Insulin oscillation The insulin concentration in blood increases after meals and gradually returns to basal levels during the next 1–2 hours. However, the basal insulin level is not stable. It oscillates with a regular period of 3-6 min. After a meal the amplitude of these oscillations increases but
Insulin lispro for postprandial glucose control. It has a shortened delay of onset, allowing slightly more flexibility than regular insulin, which requires a longer waiting period before starting a meal after injection. Both preparations should be coupled with a longer acting insulin (e.g. NPH insulin) or an insulin infusion pump for good glycemic control. Insulin lispro is an FDA approved drug used to treat people living with Type 1 diabetes or Type 2 diabetes. Insulin lispro has non-FDA labeled uses for diabetic neuropathy prevention and cardiovascular disease prevention. Common side effects include skin irritation at the site of injection, hypoglycemia, hypokalemia, and